Rodin Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 6 known investors
Healthtech
Founders & leadership
AR
Adam RosenbergExecutive
Board
BB
Bruce BoothBoard director
KB
Kees BeenBoard director
SS
Samantha SingerBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$10.8M disclosed across 1 round · 2017
▶$10.8MraisedSep 2017 · 6 investors · Other Health CareRule 506(b)
▶$10.8MraisedSep 2017 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam RosenbergExecutive Officer, Director
- Bruce BoothDirector
- Kees BeenDirector
- Samantha SingerDirector
- Offering amount
- $27.1M
- Amount sold
- $10.8M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $217.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who are Rodin Therapeutics's investors?
- Rodin Therapeutics's investors include GV (Google Ventures), Hatteras Venture Partners, Third Point Ventures, Atlas Venture, JJDC, Remeditex Ventures.
- How much funding has Rodin Therapeutics raised?
- Rodin Therapeutics has disclosed $10.8M raised across 1 round.
- Where is Rodin Therapeutics headquartered?
- Rodin Therapeutics is headquartered in Cambridge, US.